Chemours Company (The) (NYSE:CC) announced its quarterly earnings data on Wednesday. The company reported $0.08 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.29 by $0.21. The company earned $1.30 billion during the quarter, compared to the consensus estimate of $1.24 billion. Chemours Company (The) had a net margin of 2.78% and a return on equity of 81.19%.

Chemours Company (NYSE:CC) opened at 31.90 on Friday. The company has a market cap of $5.80 billion, a PE ratio of 38.62 and a beta of 3.50. The company’s 50-day moving average price is $25.57 and its 200-day moving average price is $19.23. Chemours Company has a 12-month low of $3.80 and a 12-month high of $33.00.

Earnings History for Chemours Company (The) (NYSE:CC)

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 15th. Investors of record on Monday, February 27th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Thursday, February 23rd. Chemours Company (The)’s payout ratio is currently 14.81%.

This news story was published by Daily Political and is the property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The original version of this news story can be viewed at http://www.dailypolitical.com/2017/02/16/chemours-company-the-cc-issues-quarterly-earnings-results.html.

Several brokerages have recently weighed in on CC. Jefferies Group LLC restated a “hold” rating and issued a $17.00 price objective (up previously from $15.00) on shares of Chemours Company (The) in a report on Thursday, November 10th. Goldman Sachs Group, Inc. (The) upgraded Chemours Company (The) from a “neutral” rating to a “buy” rating in a report on Monday. They noted that the move was a valuation call. Finally, Zacks Investment Research upgraded Chemours Company (The) from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective for the company in a report on Thursday, November 10th. One analyst has rated the stock with a sell rating, four have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. Chemours Company (The) presently has an average rating of “Hold” and a consensus price target of $20.65.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.

5 Day Chart for NYSE:CC

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.